Pharmacological therapies for autism spectrum disorder: a review
- PMID: 26045648
- PMCID: PMC4450669
Pharmacological therapies for autism spectrum disorder: a review
Abstract
Medications are often added to behavioral therapy to help patients with autism spectrum disorder function successfully. This review discusses approved and off-label pharmacotherapeutic options for the various symptoms of the disorder.
References
-
- American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, Virginia: American Psychiatric Publishing; 2013.
-
- Autism Speaks What is autism? 2015. Available at: http://www.autismspeaks.org/what-autism. Accessed February 6, 2015.
-
- Rice CE, Baio J, Van Naarden Braun K, et al. A public health collaboration for the surveillance of autism spectrum disorders. Paediatr Perinat Epidemiol. 2007;21:179–190. - PubMed
-
- Food and Drug Administration FDA approves the first drug to treat irritability associated with autism, Risperdal. Oct 6, 2006. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108759.... Accessed January 27, 2015.
-
- McCracken JT, McGough J, Shah B, et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002;347:314–321. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical